KreaMedica logo

KreaMedica

North America, Quebec, Canada, Montréal

Description

KreaMedica is a drug development and consulting solutions company that provides quick access to engage with right consultants/experts.

Investor Profile

KreaMedica has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (50%)
  • Germany (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does KreaMedica frequently co-invest with?

Creative Ventures
North America, California, United States, Oakland
Co-Investments: 1
Prox Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 1
Meneldor
Europe, Gelderland, The Netherlands, Druten
Co-Investments: 1
Wilson Sonsini Goodrich & Rosati
North America, California, United States, Palo Alto
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Gemseki
Asia, Tokyo, Japan, Akasaka
Co-Investments: 1

Which angels does KreaMedica often collaborate with?

JB
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by KreaMedica?

Cytonus Therapeutics

Carlsbad, California, United States

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

BiotechnologyHealth CareMedical
Series ANov 3, 2023
Amount Raised: $11,703,095
Atriva Therapeutics

Tübingen, Baden-Wurttemberg, Germany

Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series AJan 3, 2019

Find More Investors Like KreaMedica

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

KreaMedica | Pipeseed